Medtronic plc(MDT)NASDAQ
Stock Performance & Returns
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
MDT | 119.17 B | 24.96x | 9.90% | 13.20% | $3.73 | 9.84% | 0.58 | 3.16% | $103.76 | $72.65 |
HBCN.IR | - | - | - | - | - | - | - | - | - | - |
STE | 22.12 B | 27.73x | 7.30% | 13.33% | $8.18 | 11.39% | 0.28 | 1.10% | $267.96 | $194.56 |
TRIB | 7.8 M | -0.16x | - | -85.36% | $-60.00 | - | - | - | $14.17 | $0.31 |
Peer Valuation & Performance Analysis
Peer group analysis for Medtronic plc (MDT) compared to its primary competitors (including HBCN.IR, STE, TRIB) reveals distinct metrics. MDT trades at a valuation premium compared to its competitors, with a P/E ratio of 25.0x versus the peer average of 13.8x (representing a 81% premium). This indicates that the market expects superior growth or commands a quality premium for MDT. In terms of growth, MDT's revenue growth of 9.9% exceeds the peer average of 7.3%, highlighting its competitive strength and market share gains. Additionally, it boasts superior profitability with a net margin of 13.2% compared to the peer average of -36.0%, demonstrating strong cost controls and pricing power.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• MDT ranks #1 in P/E ratio, #1 in revenue growth, and #2 in profit margins
• Average ranking: #1 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-09-03 | $93.04 | $93.72 | $90.97 | $93.10 | 7,411,300 | +0.06% |
| 2026-09-02 | $92.25 | $94.61 | $91.47 | $92.18 | 9,159,400 | -0.08% |
| 2026-09-01 | $94.00 | $95.41 | $90.80 | $92.04 | 18,838,600 | -2.09% |
| 2026-08-31 | $90.75 | $91.12 | $90.04 | $90.65 | 12,630,500 | -0.11% |
| 2026-08-28 | $90.29 | $91.56 | $89.94 | $91.23 | 6,466,100 | +1.04% |
| 2026-08-27 | $91.50 | $91.61 | $89.96 | $89.97 | 7,770,900 | -1.67% |
| 2026-08-26 | $91.08 | $92.53 | $90.75 | $92.02 | 6,046,100 | +1.03% |
| 2026-08-25 | $92.28 | $92.82 | $91.11 | $91.14 | 6,799,400 | -1.24% |
| 2026-08-24 | $93.43 | $94.05 | $92.66 | $92.90 | 6,010,900 | -0.57% |
| 2026-08-21 | $92.57 | $93.55 | $91.73 | $93.35 | 7,494,500 | +0.84% |
| 2026-08-20 | $93.37 | $94.53 | $92.23 | $92.30 | 6,348,800 | -1.15% |
| 2026-08-19 | $92.38 | $94.72 | $91.95 | $94.13 | 5,636,000 | +1.89% |
| 2026-08-18 | $92.00 | $93.09 | $91.47 | $92.09 | 6,789,900 | +0.10% |
| 2026-08-17 | $90.89 | $91.79 | $90.08 | $90.60 | 7,830,300 | -0.32% |
| 2026-08-14 | $90.99 | $91.99 | $90.41 | $91.27 | 8,245,200 | +0.31% |
Explore More Analysis for MDT
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.